Squarepoint
NTRP

Squarepoint’s Neurotrope, Inc. Common NTRP Stock Holding History

Squarepoint’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50,334
Closed -$58K – 3001
2020
Q2 		$58K Buy
+50,334
New +$63K ﹤0.01% 2085
2019
Q4 		– Sell
-11,776
Closed -$10K – 2948
2019
Q3 		$10K Buy
+11,776
New +$54K ﹤0.01% 2281

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFAS
Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return
PTP
Platform Technology Partners New York $519M AUM 20% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's NTRP Position: Q3 2020 in Review

Squarepoint sold out of Neurotrope, Inc. Common (NTRP) in Q3 2020, closing a stake of 50,334 shares — an estimated $58K sold.

Squarepoint first reported a position in NTRP in Q3 2019 and held it in 2 quarters. The position peaked at $58K in Q2 2020. 34 funds tracked by Wall St. Rank hold NTRP as of Q3 2020.

  • Squarepoint reported no remaining Neurotrope, Inc. Common position as of Q3 2020 after selling out during the quarter.
  • Squarepoint sold 50,334 Neurotrope, Inc. Common shares in Q3 2020, an estimated $58K.
  • Squarepoint first reported a position in Neurotrope, Inc. Common in Q3 2019 and held it in 2 quarters.
  • Squarepoint's Neurotrope, Inc. Common position peaked at $58K in Q2 2020.
  • 34 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q3 2020.

Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.